养心氏片治疗慢性心力衰竭疗效及安全性的Meta分析

养心氏片治疗慢性心力衰竭疗效及安全性的Meta分析
陈琴月;戴小华
【期刊名称】《中西医结合心脑血管病杂志》
【年(卷),期】2018(016)002
【摘要】Objective To evaluate the clinical efficacy and safety of Yangxinshi tablets in the adjuvant treatment of chronic heart failure (CHF).Methods We searched the databases.The retrieval time was up to November 2017,the clinical randomized controlled trials (RCTs) about the efficacy of Yangxinshi tablets plus conventional western medicine versus western medicine in the treatment of CHF were collected.Meta-analysis was performed using Reviews Manger 5.3 software for Meta analysis after data extraction independently by 2 researchers and quality evaluation by modified Jadad.Results The results of 14 studies were included,all of them in Chinese,of which Jadad score was 2 in 1 article and 1 in 13 articles.Meta analysis showed that compared with control group,Yangxinshi tablets improved the clinical efficacy[OR=3.24,95％ CI (2.33,4.49),P ＜0.000 01],improved the 6 min walking distance(6 MWT)[MD =47.21,95％ CI (37.45,56.97),P ＜ 0.000 01],reduced the levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP)[-SMD =-1.57,95％ CI (-2.50,-0.63),P
=0.001],lowered the levels of high-sensitivity C-reactive protein (hs-CRP)[MD=-0.39,95％ CI (-0.80,0.02),P =0.06].There was no significant difference in the adverse reactions between two groups (P ＞
0.05).Conclusion Yangxinshi tablets in the adjuvant treatment of CHF can improve cardiac function.The existing literature quality is poor,the exact conclusion still needs further rigorous trials.%目的系统评价养心氏片辅助治疗慢性心力衰竭(CHF)的临床疗效及安全性.方法计算机检索各大数据库,检索时限为建库至2017年6月,纳入养心氏联合常规西药与常规西药治疗慢性心力衰竭的临床随机对照试验.由2名研究者独立检索文献,经Jadad改良版质量评价后纳入文献,采用Reviews Manger 5.3软件进行Meta分析.结果共纳入14个研究,全部为中文文献,Jadad评分1篇为2分,13篇为1分.Meta分析结果显示,试验组与对照组比较,试验组可提高病人临床疗效,OR=3.24,95％CI[2.33,4.49],P＜0.000 01;提高6 min步行距离(6MWT),平均差(MD)=47.21,95％ CI [37.45,56.97],P＜0.000 01;降低N末端脑钠肽前体(NT-proBNP),标准化均数差(SMD)=-1.57,95％ CI [-2.50,-0.63],P=0.001;降低超敏C反应蛋白(hs-CRP),MD=-0.39,95％ CI[-
0.80,0.02],P=0.06.服用养心氏片后,个别病例出现干咳、上腹部不适、胃胀等不良反应,均可耐受,与对照组比较,差异无统计学意义(P＞0.05).结论养心氏片辅助治疗慢性心力衰竭,可改善心功能,但现有文献质量偏低,确切结论仍需进一步严格试验证实.
【总页数】5页(P129-133)
【作者】陈琴月;戴小华
【作者单位】安徽中医药大学合肥 230038;安徽中医药大学合肥 230038
【正文语种】中文
【中图分类】R541.6;R256.2
【相关文献】
1.芪苈强心胶囊治疗慢性心力衰竭疗效及安全性的Meta分析 [J], 李朝阳;韩涛;李金海;曹权
2.养心氏片治疗心律失常临床疗效及安全性的Meta分析 [J], 许笑雯;李益萍;阮小芬;王肖龙
3.生脉散加减治疗慢性心力衰竭气阴两虚证疗效及安全性的Meta分析 [J], 王兴; 侯平
4.振源胶囊辅助治疗慢性心力衰竭疗效及安全性的Meta分析 [J], 伍长娟;汤天生
5.振源胶囊联合常规西药治疗慢性心力衰竭疗效及安全性Meta分析 [J], 王茹;王培利;陶庄;王承龙
因版权原因，仅展示原文概要，查看原文内容请购买。